Inactivation of mutagenic heterocyclic and aryl amines by linoleic acid 13-monohydroperoxide and methemoglobin.
Kato
T
T
Tokyo College of Pharmacy, Japan.
Takahashi
T
T
Kikugawa
K
K
D000588:Amines / Q000037:antagonists & inhibitors*; D002243:Carbolines / Q000037:antagonists & inhibitors; D005449:Fluorenes / Q000378:metabolism; D005609:Free Radicals; D006571:Heterocyclic Compounds / Q000037:antagonists & inhibitors*; D008041:Linoleic Acids / Q000494:pharmacology*; D015227:Lipid Peroxidation; D008054:Lipid Peroxides / Q000494:pharmacology*; D008706:Methemoglobin / Q000494:pharmacology*; D009153:Mutagens / Q000037:antagonists & inhibitors*; D012486:Salmonella typhimurium / Q000187:drug effects
D000588:Amines; D002243:Carbolines; D005449:Fluorenes; D005609:Free Radicals; D006571:Heterocyclic Compounds; D008041:Linoleic Acids; D008054:Lipid Peroxides; D009153:Mutagens; C008285:linoleic acid hydroperoxide; C012177:2-aminofluorene; C019133:3-amino-1-methyl-5H-pyrido(4,3-b)indole; D008706:Methemoglobin; C019132:3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole